Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01937585 · ClinicalTrials.gov registry record · NA

Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men

A NA study, sponsored by Fox Chase Cancer Center.

Completed
Registry status
NA
Development phase
231
Enrollment target

NCT01937585: Completed NA study, sponsored by Fox Chase Cancer Center.

NCT01937585 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 231 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01937585, a NA study, has completed, sponsored by Fox Chase Cancer Center.

COMPLETED
Registry status
NA
Development phase
231 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether female partners of African American men can promote initiation of a discussion with a healthcare provider about prostate cancer screening when the partner is supported by a print message designed to provide relevant information and strategies for her to use in this effort.

Interventions

  • BEHAVIORAL Partner and CDC brochure condition
  • BEHAVIORAL CDC brochure only condition

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2010-08
Est. Completion 2010-11
Phase NA
Fox Chase Cancer Center

183 total trials

What the finished NCT01937585 record still lists

NCT01937585 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Partner and CDC brochure condition is the first listed.

NCT01937585 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01937585 about?

NCT01937585 is a clinical study titled "Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men". The purpose of this study is to determine whether female partners of African American men can promote initiation of a discussion with a healthcare provider about prostate cancer screening when the partner is supported by a print message designed to provide relevant information and strategies for her...

What is the current status of trial NCT01937585?

This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2010-08. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01937585?

The interventions under investigation include: Partner and CDC brochure condition (BEHAVIORAL), CDC brochure only condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT01937585?

This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01937585's enrollment target sits among peer trials

231 465th of 2000 higher than 1,536 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04077099 · 231 participants · Phase 1

    A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

  • NCT05019495 · 231 participants · NA

    Optimizing Tobacco Treatment Delivery for People Living With HIV

  • NCT06023589 · 231 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • NCT06734351 · 231 participants · Phase 3

    A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01937585, the US trial registry maintained by the National Library of Medicine. NCT01937585 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.